Skip to main content
Premium Trial:

Request an Annual Quote

Clydesdale Bank Invests $7.8M into Lab21

NEW YORK (GenomeWeb News) – Clydesdale Bank has provided diagnostics firm Lab21 with £5 million ($7.8 million) to support the company's growth plans.

Lab21, based in Cambridge, UK, provides diagnostics products and services for companion diagnostics in personalized medicine, blood bank screening, and other clinical diagnostics.

In recent months, it has partnered with undisclosed companies to develop molecular diagnostic products for detecting mutations in colorectal cancer samples and for detecting Aspergillus. In March, Lab21 opened a clinical genomics center within the Greenville Hospital System Memorial Medical Campus in Greenville, SC.

Susan Lowther, CFO of Lab21, said in a statement today that it intends to use the Clydesdale investment to expand it GMP manufacturing capability and its international sales channel with an eye toward the US market.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.